Etcamah
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Etcamah, covering 2026-07-21 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Etcamah (camizestrant) — AstraZeneca AB
1 regulatory and trial event tracked for Etcamah, covering 2026-07-21 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Etcamah (camizestrant) — AstraZeneca AB